A detailed history of Mai Capital Management transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Mai Capital Management holds 283,199 shares of VOR stock, worth $314,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares
283,199
Previous 475,891 40.49%
Holding current value
$314,350
Previous $333,000 5.71%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$0.64 - $1.27 $123,322 - $244,718
-192,692 Reduced 40.49%
283,199 $314,000
Q3 2024

Nov 07, 2024

BUY
$0.7 - $1.1 $4,076 - $6,405
5,823 Added 1.24%
475,891 $333,000
Q2 2024

Aug 12, 2024

BUY
$1.0 - $2.2 $104,209 - $229,259
104,209 Added 28.48%
470,068 $470,000
Q1 2024

May 08, 2024

BUY
$1.8 - $2.85 $15,674 - $24,817
8,708 Added 2.44%
365,859 $867,000
Q4 2023

Feb 09, 2024

BUY
$1.66 - $2.63 $592,870 - $939,307
357,151 New
357,151 $803,000

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $42.2M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.